Literature DB >> 19258716

Discordance for X-linked hypophosphataemic rickets in identical twin girls.

Catherine J Owen1, Abdul Habeb, Simon H S Pearce, Michael Wright, Shoji Ichikawa, Andrea H Sorenson, Michael J Econs, Tim D Cheetham.   

Abstract

BACKGROUND: We report monozygotic twin girls with a family history consistent with X-linked hypophosphataemic rickets (XLH). One twin had a skeletal and biochemical phenotype consistent with XLH, whilst the second twin appeared normal. Complete non-penetrance in XLH has not been previously reported and our aim was to explore potential reasons for this.
METHODS: Serum and urine biochemistry were analysed at regular intervals. Microsatellite analysis was performed to confirm monozygosity and bi-parental inheritance of the X chromosome. The X chromosome inactivation pattern was studied in peripheral blood. Exons of the paternal PHEX and FGF23 genes were sequenced.
RESULTS: Biochemistry was persistently abnormal in the slow-growing twin 1 and normal in twin 2 who has grown normally. Maximal tubular phosphate reabsorption was 0.68 mmol/l in twin 1 and 1.64 mmol/l in twin 2 at 10.8 years of age (normal 1.15-2.58 mmol/l). Microsatellite analysis confirmed monozygosity and the X chromosome inactivation pattern was random. These studies also excluded uniparental isodisomy. The exon sequence of paternal PHEX and FGF23 genes was normal.
CONCLUSIONS: Discordant X inactivation is a well-recognised phenomenon in identical twins, and we suspect that non-random expression of the normal PHEX gene in critical tissues is the most likely explanation for non-penetrance. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258716     DOI: 10.1159/000201113

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.

Authors:  Mary D Ruppe; Patrick G Brosnan; Kit Sing Au; Phong X Tran; Barbara W Dominguez; Hope Northrup
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

Review 2.  FGF23 and syndromes of abnormal renal phosphate handling.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 3.  Upstream Regulators of Fibroblast Growth Factor 23.

Authors:  Danielle M A Ratsma; M Carola Zillikens; Bram C J van der Eerden
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.